Eliminating the effect of PCSK9, whether via direct inhibition or gene knock-out, was shown to attenuate tumor growth in mice cancer cells by decreasing the barriers or checkpoints to T call signaling, which then boosts the anti-tumor immune response to cancer cells [51]. The gene discussed is PCSK9; the disease is neoplasm.